Previous Close | 13.10 |
Open | 13.12 |
Bid | 12.98 x 100 |
Ask | 13.04 x 100 |
Day's Range | 12.94 - 13.28 |
52 Week Range | 9.57 - 21.60 |
Volume | |
Avg. Volume | 356,631 |
Market Cap | 485.912M |
Beta (5Y Monthly) | 1.05 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
13D FILINGS These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5% in any class of a company’s securities.
Orthofix's (OFIX) fourth-quarter earnings and revenues beat their respective consensus estimate. Gross margin expands while the company continues to incur losses at the operating level.
Orthofix Medical Inc (OFIX) released its 8-K filing on March 5, 2024, showcasing a year of substantial growth and operational efficiency